T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses ...
Feb 18, 2022
0
23
A new mutation was identified in 9 percent of relapsed cases of pediatric acute myeloid leukemia (AML) that may define a new subtype of the disease. While the researchers identified the mutation in samples of relapsed AML, ...
Feb 17, 2022
0
2
Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care. This first-of-its-kind report provides a comprehensive view of the burden ...
Feb 9, 2022
0
77
Compared to U.S. urban adults, rural adults were more likely to think fatalistically about cancer and feel overwhelmed by information about cancer prevention, according to results published in Cancer Epidemiology, Biomarkers ...
Jan 30, 2022
0
19
Individuals between 20 and 39 years old experienced the steepest increase in distant-stage early-onset colorectal adenocarcinoma incidence between 2000 and 2016, with the youngest non-Hispanic Black and Hispanic populations ...
Jan 26, 2022
0
4
Independent drug action, not synergy nor additivity, accounted for the clinical efficacy of nearly all examined combination therapies involving immune checkpoint inhibitors in clinical trials, according to results from a ...
Jan 19, 2022
0
5
For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly ...
Jan 12, 2022
0
8
The first classification of pediatric cancers soon to be published by the International Agency for Research on Cancer (IARC) as part of the new World Health Organization (WHO) Classification of Tumors series was summarized ...
Dec 17, 2021
0
6
Blood Cancer Discovery, a journal of the American Association for Cancer Research, has published a research article demonstrating a novel approach that may reduce a serious adverse effect associated with chimeric antigen ...
Dec 15, 2021
0
1
Among patients with hormone receptor-positive breast cancer treated with an aromatase inhibitor plus palbociclib (Ibrance), those who displayed a rising ESR1 mutation detected in their blood before disease progression doubled ...
Dec 9, 2021
0
3
